These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7954269)

  • 1. Cisplatin-associated hemolytic uremic syndrome.
    Canpolat C; Pearson P; Jaffe N
    Cancer; 1994 Dec; 74(11):3059-62. PubMed ID: 7954269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic-uremic syndrome associated with neoadjuvant chemotherapy in the treatment of advanced cervical cancer.
    Angiola G; Bloss JD; DiSaia PJ; Warner AS; Manetta A; Berman ML
    Gynecol Oncol; 1990 Nov; 39(2):214-7. PubMed ID: 1699855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.
    Saif MW; McGee PJ
    JOP; 2005 Jul; 6(4):369-74. PubMed ID: 16006690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.
    Lee HW; Chung MJ; Kang H; Choi H; Choi YJ; Lee KJ; Lee SW; Han SH; Kim JS; Song SY
    Gut Liver; 2014 Jan; 8(1):109-12. PubMed ID: 24516709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-related hemolytic-uremic syndrome following treatment of a carcinoma of the nasopharynx.
    Thurnher D; Kletzmayr J; Formanek M; Quint C; Czerny C; Burian M; Kornek G
    Oncology; 2001; 61(2):143-6. PubMed ID: 11528253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of literature.
    Gottschall JL; Neahring B; McFarland JG; Wu GG; Weitekamp LA; Aster RH
    Am J Hematol; 1994 Dec; 47(4):283-9. PubMed ID: 7977300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin-associated hemolytic-uremic syndrome.
    Allan DS; Thompson CM; Barr RM; Clark WF; Chin-Yee IH
    Ann Pharmacother; 2002 Jun; 36(6):1000-2. PubMed ID: 12022900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of cisplatin-induced hemolytic uremic syndrome with therapeutic plasma exchange.
    Palmisano J; Agraharkar M; Kaplan AA
    Am J Kidney Dis; 1998 Aug; 32(2):314-7. PubMed ID: 9708619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin-associated hemolytic-uremic syndrome. Successful treatment with a staphylococcal protein A column.
    Watson PR; Guthrie TH; Caruana RJ
    Cancer; 1989 Oct; 64(7):1400-3. PubMed ID: 2528403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
    Jenssen GR; Vold L; Hovland E; Bangstad HJ; Nygård K; Bjerre A
    BMC Infect Dis; 2016 Jun; 16():285. PubMed ID: 27297224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide tolerance in osteosarcoma patients previously treated with cis-diamminedichloroplatinum-II: renal, hematologic, and neurologic observations.
    Canpolat C; Pearson P; Robertson R; Jaffe N
    Med Pediatr Oncol; 1996 Jan; 26(1):36-47. PubMed ID: 7494510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
    Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
    Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
    Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemolytic uremic syndrome by Streptococcus pneumoniae].
    Herrero-Morín JD; Fernández N; Santos F; Rey C; Málaga S
    Nefrologia; 2007; 27(4):505-8. PubMed ID: 17944589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic uremic syndrome following cisplatin, bleomycin, and vincristine chemotherapy: a report of a case and a review of the literature.
    Gardner G; Mesler D; Gitelman HJ
    Ren Fail; 1989; 11(2-3):133-7. PubMed ID: 2482985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma.
    Kalra N; Kad R; Osama S
    Int J Clin Oncol; 2007 Oct; 12(5):385-7. PubMed ID: 17929123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic uremic syndrome in children.
    Talarico V; Aloe M; Monzani A; Miniero R; Bona G
    Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome-related complex in a patient with metastatic prostate cancer?
    Shrestha A; Khosla P; Wei Y
    Am J Ther; 2011 Sep; 18(5):e167-71. PubMed ID: 20592666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual toxic cause of hemolytic-uremic syndrome.
    Nayak SG; Satish R; Gokulnath
    J Toxicol Sci; 2007 May; 32(2):197-9. PubMed ID: 17538244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.